• Return to Headlines

Repligen Corp Shares Up 39.3% Since SmarTrend's Buy Recommendation (RGEN)

By Amy Schwartz

SmarTrend identified an Uptrend for Repligen Corp (NASDAQ:RGEN) on April 26th, 2019 at $63.80. In approximately 4 months, Repligen Corp has returned 39.31% as of today's recent price of $88.87.

Repligen Corp share prices have moved between a 52-week high of $99.25 and a 52-week low of $29.56 and are now trading 201% above that low price at $88.87 per share. Over the past week, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.5%.

Repligen Corporation is a bioprocessing company focused on the development, production and commercialization of innovative products used in the process of manufacturing biologic drugs. The Company's customers include life sciences companies, global biopharmaceutical companies, and contract manufacturers worldwide.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Repligen Corp shares.

Log in and add Repligen Corp (RGEN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights repligen corp

Ticker(s): RGEN